股本结构
单位：万股
| 公告日期 | 2024-03-11 | 2024-03-11 | 2023-12-12 | 2023-11-14 | 2023-10-30 | 2023-11-14 |
|---|---|---|---|---|---|---|
| 证券总股本 | 1039.01 | 922.03 | 921.97 | 921.72 | 921.72 | 829.64 |
| 普通股本 | 1039.01 | 922.03 | 921.97 | 921.72 | 921.72 | 829.64 |
| 优先股 | 25.00 | 25.00 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-08 | 2023-12-31 | 2023-12-05 | 2023-11-10 | 2023-10-30 | 2023-09-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-11 | 1039.01 | 25.00 | 定期报告 | 2024-03-08 |
| 2024-03-11 | 922.03 | 25.00 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common shares - Annual Stock Dividend
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, net of offering costs - Registered Direct Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
Reverse Split (15:1) adjustment
|
2023-12-31 |
| 2023-12-12 | 921.97 | 未披露 | 定期报告 | 2023-12-05 |
| 2023-11-14 | 921.72 | 未披露 | 定期报告 | 2023-11-10 |
| 2023-10-30 | 921.72 | 未披露 |
更多>>
Securities Offered 920,000 shares by the company
|
2023-10-30 |
| 2023-10-30 | 829.72 | 未披露 | 定期报告 | 2023-10-23 |
| 2023-11-14 | 829.64 | 25.00 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares, net of offering costs - At-the-Market Offering
|
2023-09-30 |
| 2023-08-14 | 820.46 | 未披露 | 定期报告 | 2023-08-10 |
| 2023-08-14 | 732.04 | 25.00 | 定期报告 | 2023-06-30 |
| 2023-05-12 | 816.09 | 未披露 | 定期报告 | 2023-05-10 |
| 2023-04-28 | 815.33 | 未披露 | 定期报告 | 2023-04-25 |
| 2023-04-03 | 730.00 | 未披露 |
更多>>
Mustang Bio, Inc. announced that it will effect a 15-for-1 reverse stock split of its issued and outstanding common stock.
|
2023-04-04 |
| 2023-04-03 | 10940.00 | 未披露 | 定期报告 | 2023-04-03 |
| 2023-03-30 | 11024.40 | 未披露 | 定期报告 | 2023-03-27 |
| 2023-03-13 | 11021.98 | 25.00 | 定期报告 | 2023-03-03 |
| 2023-03-30 | 10734.70 | 25.00 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on RWG Debt
Stock-based compensation expenses
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares - Founders Agreement
Issuance of common shares under ESPP
|
2022-12-31 |
| 2022-11-14 | 10730.42 | 未披露 | 定期报告 | 2022-11-11 |
| 2022-11-14 | 10727.32 | 25.00 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2022-09-30 |
| 2022-08-11 | 10606.70 | 未披露 | 定期报告 | 2022-08-09 |
| 2022-08-11 | 10535.66 | 25.00 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Stock-based compensation expenses
|
2022-06-30 |
| 2022-05-12 | 10304.68 | 未披露 | 定期报告 | 2022-05-10 |
| 2022-04-29 | 10247.92 | 25.00 | 定期报告 | 2022-04-25 |
| 2022-05-12 | 10113.32 | 25.00 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares - Equity fee on RWG debt
|
2022-03-31 |
| 2022-03-23 | 10029.08 | 未披露 | 定期报告 | 2022-03-18 |
| 2022-03-23 | 9442.84 | 25.00 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Correction to previously issued shares
Stock-based compensation expenses
Exercise of warrants
Common stock issuable - Founders Agreement
Issuance of common shares - Founders Agreement
|
2021-12-31 |
| 2021-11-12 | 9342.78 | 未披露 | 定期报告 | 2021-11-10 |
| 2021-11-12 | 9200.52 | 25.00 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2021-09-30 |
| 2021-08-16 | 9140.25 | 未披露 | 定期报告 | 2021-08-13 |
| 2021-08-16 | 9078.15 | 25.00 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2021-06-30 |
| 2021-05-14 | 8731.33 | 未披露 | 定期报告 | 2021-05-13 |
| 2021-04-30 | 8654.79 | 未披露 | 定期报告 | 2021-04-20 |
| 2021-05-14 | 8588.85 | 25.00 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
|
2021-03-31 |
| 2021-03-24 | 8517.48 | 未披露 | 定期报告 | 2021-03-23 |
| 2021-03-24 | 7176.61 | 25.00 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Issuance of common shares under ESPP
Exercise of warrants
|
2020-12-31 |
| 2020-11-13 | 6559.35 | 未披露 | 定期报告 | 2020-11-12 |
| 2020-11-06 | 6523.84 | 未披露 | 定期报告 | 2020-11-04 |
| 2020-11-06 | 6100.99 | 25.00 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
|
2020-09-30 |
| 2020-08-10 | 5657.37 | 未披露 | 定期报告 | 2020-08-09 |
| 2020-08-10 | 5567.16 | 25.00 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares, equity fee on Public Offering
Stock-based compensation expenses
|
2020-06-30 |
| 2020-04-29 | 4298.32 | 25.00 | 定期报告 | 2020-04-20 |
| 2020-05-11 | 4292.22 | 25.00 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
|
2020-03-31 |
| 2020-03-16 | 4284.48 | 未披露 | 定期报告 | 2020-03-13 |
| 2020-03-16 | 4024.89 | 25.00 |
更多>>
From December 31, 2018 to December 31, 2019
Conversion of Class A common shares to common shares
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
|
2019-12-31 |
| 2019-11-12 | 4056.35 | 未披露 | 定期报告 | 2019-11-11 |
| 2019-11-12 | 4044.08 | 25.00 |
更多>>
from June 30, 2019 to September 30, 2019
Stock-based compensation expenses
Exercise of warrants
|
2019-09-30 |
| 2019-08-16 | 4047.24 | 25.00 | 定期报告 | 2019-08-15 |
| 2019-08-09 | 4045.04 | 未披露 | 定期报告 | 2019-08-08 |
| 2019-08-09 | 4045.43 | 25.00 |
更多>>
from March 31, 2019 to June 30, 2019
Conversion of Class A common shares to common shares
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
|
2019-06-30 |
| 2019-05-10 | 4025.92 | 未披露 |
更多>>
On April 30, 2019, Mustang announced the pricing of an underwritten public offering, whereby it sold 6,875,000 shares of its common stock, (plus a 30-day option to purchase up to an additional 1,031,250 shares of common stock, which was fully exercised) at a price of $4.00 per share for gross proceeds of approximately $31.6 million.
|
2019-05-09 |
| 2019-05-02 | 3822.89 | 未披露 | 定期报告 | 2019-05-02 |
| 2019-04-30 | 3221.63 | 未披露 | 定期报告 | 2019-04-26 |
| 2019-04-29 | 3215.53 | 未披露 | 定期报告 | 2019-04-23 |
| 2019-05-10 | 2856.14 | 25.00 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Stock-based compensation expenses
Exercise of warrants
|
2019-03-31 |
| 2019-03-18 | 2831.95 | 未披露 | 定期报告 | 2019-03-17 |
| 2019-03-18 | 2761.02 | 25.00 |
更多>>
from December 31, 2017 to December 31, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
|
2018-12-31 |
| 2018-11-13 | 2726.36 | 25.00 |
更多>>
from December 31, 2017 to September 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
|
2018-09-30 |
| 2018-08-13 | 2726.34 | 25.00 |
更多>>
From December 31, 2017 to June 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
|
2018-06-30 |
| 2018-05-14 | 2711.24 | 未披露 | 定期报告 | 2018-05-13 |
| 2018-04-30 | 2710.49 | 未披露 | 定期报告 | 2018-04-16 |
| 2018-05-14 | 2710.16 | 25.00 |
更多>>
from December 31, 2017 to March 31, 2018
Issuance of common shares - Founders Agreement
Exercise of warrants
|
2018-03-31 |
| 2018-03-29 | 2709.66 | 未披露 | 定期报告 | 2018-03-28 |
| 2018-03-29 | 2623.63 | 25.00 |
更多>>
from December 31, 2016 to December 31, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses
Exercise of NSC warrants
|
2017-12-31 |
| 2017-11-14 | 2623.21 | 25.00 |
更多>>
From December 31, 2016 to September 30, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses
|
2017-09-30 |
| 2017-08-22 | 2622.19 | 未披露 | 定期报告 | 2017-08-22 |
| 2017-03-31 | 1616.52 | 25.00 | 定期报告 | 2016-12-31 |
From December 31,2022 to December 31,2023
Issuance of common shares - Annual Stock Dividend
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, net of offering costs - Registered Direct Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
Reverse Split (15:1) adjustment
Securities Offered 920,000 shares by the company
From June 30, 2023 to September 30, 2023
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares, net of offering costs - At-the-Market Offering
Mustang Bio, Inc. announced that it will effect a 15-for-1 reverse stock split of its issued and outstanding common stock.
From December 31, 2021 to December 31, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on RWG Debt
Stock-based compensation expenses
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares - Founders Agreement
Issuance of common shares under ESPP
From June 30, 2022 to September 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From March 31, 2022 to June 30, 2022
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Stock-based compensation expenses
From December 31, 2021 to March 31, 2022
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Issuance of common shares - Equity fee on RWG debt
From December 31, 2020 to December 31, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Correction to previously issued shares
Stock-based compensation expenses
Exercise of warrants
Common stock issuable - Founders Agreement
Issuance of common shares - Founders Agreement
From June 30, 2021 to September 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From March 31, 2021 to June 30, 2021
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From December 31, 2020 to March 31, 2021
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
from December 31, 2019 to December 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Issuance of common shares under ESPP
Exercise of warrants
From June 30, 2020 to September 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
From March 31, 2020 to June 30, 2020
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares, equity fee on Public Offering
Stock-based compensation expenses
From December 31, 2019 to March 31, 2020
Issuance of common shares - Founders Agreement
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares, equity fee on At-the-Market Offering
Issuance of common shares under ESPP
Stock-based compensation expenses
Exercise of warrants
From December 31, 2018 to December 31, 2019
Conversion of Class A common shares to common shares
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
from June 30, 2019 to September 30, 2019
Stock-based compensation expenses
Exercise of warrants
from March 31, 2019 to June 30, 2019
Conversion of Class A common shares to common shares
Issuance of common shares, net of offering costs - At-the-Market Offering
Issuance of common shares - Equity fee on At-the-Market Offering
Issuance of common shares, net of offering costs - Public Offering
Issuance of common shares - Equity fee on Public Offering
Stock-based compensation expenses
Exercise of warrants
On April 30, 2019, Mustang announced the pricing of an underwritten public offering, whereby it sold 6,875,000 shares of its common stock, (plus a 30-day option to purchase up to an additional 1,031,250 shares of common stock, which was fully exercised) at a price of $4.00 per share for gross proceeds of approximately $31.6 million.
from December 31, 2018 to March 31, 2019
Issuance of common shares - Founders Agreement
Issuance of common shares - Equity fee on Horizon Notes to Fortress Biotech
Stock-based compensation expenses
Exercise of warrants
from December 31, 2017 to December 31, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
from December 31, 2017 to September 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
From December 31, 2017 to June 30, 2018
Issuance of common shares - Founders Agreement
Stock-based compensation expenses
Exercise of warrants
from December 31, 2017 to March 31, 2018
Issuance of common shares - Founders Agreement
Exercise of warrants
from December 31, 2016 to December 31, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses
Exercise of NSC warrants
From December 31, 2016 to September 30, 2017
Issuance of common shares - Founders Agreement
Issuance of common shares for license expenses
Issuance of common shares and warrants for cash
Stock-based compensation expenses